thymidine has been researched along with Gastric Diseases in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Biological activity assays of EGF(1-53), EGF(1-52), and EGF(1-51) gave almost identical thymidine uptake dose-response curves (maximal responses increasing baseline uptake from 4400 (600) cpm (mean (SEM)) to about 22 000 (2000) cpm when EGF was added at 1." | 1.31 | Potency and stability of C terminal truncated human epidermal growth factor. ( Berlanga-Acosta, J; Calnan, DP; Edwards, AD; Fagbemi, A; Lakhoo, K; Marchbank, T; Playford, RJ; Sizer, T, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blokhina, NG | 1 |
| Romanova, LF | 1 |
| Ozherel'ev, AS | 1 |
| Lotokov, AM | 1 |
| Efimov, ON | 1 |
| Calnan, DP | 1 |
| Fagbemi, A | 1 |
| Berlanga-Acosta, J | 1 |
| Marchbank, T | 1 |
| Sizer, T | 1 |
| Lakhoo, K | 1 |
| Edwards, AD | 1 |
| Playford, RJ | 1 |
| Kaku, H | 1 |
| Lipkin, M | 1 |
4 other studies available for thymidine and Gastric Diseases
| Article | Year |
|---|---|
[Determination of the labeling index in specimens of gastric mucosa in nontumorous diseases].
Topics: Gastric Mucosa; Humans; Kinetics; Methods; Precancerous Conditions; Stomach Diseases; Stomach Neopla | 1984 |
Potency and stability of C terminal truncated human epidermal growth factor.
Topics: Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Stability; Epidermal Growth Fa | 2000 |
[Dynamic analysis of the stomach epithelium - 3H-thymidine autoradiographic study].
Topics: Animals; Autoradiography; Cardia; Cell Division; Cricetinae; DNA; Epithelial Cells; Gastric Mucosa; | 1966 |
Cell proliferation in gastrointestinal disease.
Topics: Atrophy; Autoradiography; Biopsy; Cell Division; DNA; DNA, Neoplasm; Epithelial Cells; Epithelium; F | 1969 |